Cargando…
Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes
BACKGROUND: Although type 1 diabetes (T1D) is typically described as a T cell-mediated autoimmune disease, increasing evidence for a role of B cells has emerged. However, the pivotal disease-relevant B cell subset and its contribution to islet autoimmunity remain elusive. METHODS: The frequencies an...
Autores principales: | Ling, Qing, Shen, Lei, Zhang, Wei, Qu, DuoDuo, Wang, Hongdong, Wang, Bin, Liu, Yong, Lu, Jing, Zhu, Dalong, Bi, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818172/ https://www.ncbi.nlm.nih.gov/pubmed/35123388 http://dx.doi.org/10.1186/s10020-022-00447-y |
Ejemplares similares
-
Plasmablastic plasma cell myeloma mimicking plasmablastic lymphoma
por: Choi, Qute, et al.
Publicado: (2010) -
One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study
por: Lu, Jing, et al.
Publicado: (2021) -
Glycyrrhizin inhibits LPS-induced inflammatory responses in goat ruminal epithelial cells in vitro
por: Liu, Junfeng, et al.
Publicado: (2023) -
Increased IL-12 inhibits B cells' differentiation to germinal center cells and promotes differentiation to short-lived plasmablasts
por: Kim, Sun Jung, et al.
Publicado: (2008) -
Peripheral Administration of NMU Promotes White Adipose Tissue Beiging and Improves Glucose Tolerance
por: Yuan, Yue, et al.
Publicado: (2021)